COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT01407822
Brief Title: Erlotinib Versus Gemcitabine/Cisplatin as (Neo)Adjuvant Treatment in Non-small Cell Lung Cancer (EMERGING)

First Submitted : July 26, 2011
First Submitted that Met QC Criteria : August 1, 2011
First Posted : August 2, 2011 (Estimate)

Last Update Submitted that Met QC Criteria : September 9, 2018
Last Update Posted : September 11, 2018